We are live on
!
Find out more
WIA
Westview Investment Advisors Portfolio holdings
AUM
$204M
This Fund
S&P 500
This Quarter
Est. Return
+19.97%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$12.2M
(+6.3%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
38.66%
Holding
75
New
5
Increased
16
Reduced
44
Closed
8
Avg Time Held
1.8
quarters
Top 10 Avg Time Held
1.6
quarters
Top 20 Avg Time Held
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ares Management
ARES
|
+$2.98M |
| 2 |
Constellation Energy
CEG
|
+$2.85M |
| 3 |
Fidelity Clean Energy ETF
FRNW
|
+$1.79M |
| 4 |
BlackRock MuniYield Quality Fund III
MYI
|
+$1.04M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$3.73M |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.7M |
| 3 |
Waste Connections
WCN
|
+$2.87M |
| 4 |
Intuit
INTU
|
+$2.76M |
| 5 |
Tractor Supply
TSCO
|
+$2.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.52% |
| 2 | Technology | 15.69% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 5.95% |
| 5 | Financials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$881B
| $3.03M | 1.48% |
9,261
-302
| -3% | -$93.8K |
2025 Q4
2 quarters
|
|
27
Vertex Pharmaceuticals
VRTX
$123B
| $2.97M | 1.45% |
5,981
+127
| +2% | +$56.3K |
2025 Q4
2 quarters
|
|
28
Charles Schwab
SCHW
$166B
| $2.8M | 1.37% |
30,304
-308
| -1% | -$28.1K |
2025 Q4
2 quarters
|
|
29
CRH
CRH
$53.3B
| $2.78M | 1.36% |
25,956
-916
| -3% | -$101K |
2025 Q4
2 quarters
|
|
|
30
Ares Management
ARES
$26.3B
| $2.77M | 1.35% |
+24,851
| New | +$2.98M |
2026 Q2
0 quarters
|
|
31
Shell
SHEL
$293B
| $2.58M | 1.26% |
33,246
-2,257
| -6% | -$195K |
2025 Q4
2 quarters
|
|
|
32
Constellation Energy
CEG
$105B
| $2.51M | 1.23% |
+10,123
| New | +$2.85M |
2026 Q2
0 quarters
|
|
33
Costco
COST
$423B
| $2.49M | 1.22% |
2,661
+48
| +2% | +$47.8K |
2025 Q4
2 quarters
|
|
34
Simpson Manufacturing
SSD
$7.06B
| $2.36M | 1.16% |
11,286
-179
| -2% | -$33.5K |
2025 Q4
2 quarters
|
|
35
Broadcom
AVGO
$1.71T
| $2.21M | 1.08% |
5,852
+130
| +2% | +$52.1K |
2026 Q1
1 quarter
|
|
36
Sherwin-Williams
SHW
$78.7B
| $2.05M | 1% |
5,947
-232
| -4% | -$74.1K |
2025 Q4
2 quarters
|
|
37
iShares MSCI USA Value Factor ETF
VLUE
$9.26B
| $2.01M | 0.99% |
10,081
-318
| -3% | -$57K |
2026 Q1
1 quarter
|
|
38
Vanguard Russell 1000 Growth ETF
VONG
$47.8B
| $2M | 0.98% |
15,613
+4
| +0% | +$496 |
2025 Q4
2 quarters
|
|
39
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
| $1.94M | 0.95% |
6,407
+407
| +7% | +$117K |
2025 Q4
2 quarters
|
|
40
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $1.93M | 0.94% |
52,225
-257
| -0.5% | -$8.85K |
2025 Q4
2 quarters
|
|
41
Aaon
AAON
$7.11B
| $1.91M | 0.94% |
15,091
+191
| +1% | +$22.4K |
2025 Q4
2 quarters
|
|
42
Schwab US Dividend Equity ETF
SCHD
$111B
| $1.81M | 0.89% |
57,186
+556
| +1% | +$17.6K |
2025 Q4
2 quarters
|
|
43
Veracyte
VCYT
$3.47B
| $1.79M | 0.88% |
30,563
-38
| -0.1% | -$1.59K |
2025 Q4
2 quarters
|
|
|
44
Fidelity Clean Energy ETF
FRNW
$90.6M
| $1.74M | 0.85% |
+71,395
| New | +$1.79M |
2026 Q2
0 quarters
|
|
45
TG Therapeutics
TGTX
$8.32B
| $1.61M | 0.79% |
29,224
-37
| -0.1% | -$1.51K |
2025 Q4
2 quarters
|
|
46
argenx
ARGX
$50.5B
| $1.58M | 0.78% |
1,707
-29
| -2% | -$23.9K |
2026 Q1
1 quarter
|
|
47
BlackRock MuniHoldings Fund
MHD
$1.8B
| $1.46M | 0.71% |
122,349
+3,311
| +3% | +$38.7K |
2026 Q1
1 quarter
|
|
|
48
BlackRock MuniYield Quality Fund III
MYI
$1.17B
| $1.28M | 0.63% |
115,250
+95,350
| +479% | +$1.04M |
2025 Q4
2 quarters
|
|
|
49
Neurocrine Biosciences
NBIX
$13.7B
| $1.16M | 0.57% |
+6,883
| New | +$1.02M |
2026 Q2
0 quarters
|
|
50
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $1.03M | 0.51% |
19,731
-3,470
| -15% | -$182K |
2025 Q4
2 quarters
|
|
Similar funds
BAH
CPL
WAC
BPMC
PS
12CM
MCS
EHWM
Westview Investment Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Westview Investment Advisors held 75 positions worth $204M, up 6.3% from $192M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Westview Investment Advisors withdrew a net $10.5M in Q2 2026, closing 8 positions and reducing 44 holdings. Its most notable exit was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $3.73M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 54% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Westview Investment Advisors opened a new position in Ares Management worth $2.77M.
- Westview Investment Advisors's largest Q2 2026 buy was Ares Management: 24,851 shares worth $2.77M.
- Westview Investment Advisors added most to BlackRock MuniYield Quality Fund III in Q2 2026, an estimated $1.04M increase.
- Westview Investment Advisors's biggest Q2 2026 reduction was Nuveen Municipal Credit Income Fund, cutting an estimated $531K.
- Westview Investment Advisors fully exited State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2026, selling an estimated $3.73M.
- Westview Investment Advisors's ten largest holdings make up 39% of its $204M portfolio in Q2 2026.
- Westview Investment Advisors opened 5 new positions and closed 8 in Q2 2026.
- Westview Investment Advisors's portfolio value rose 6.3% quarter-over-quarter to $204M.
Based on Westview Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.